Ramsay/RHC
Ramsay have now sold their Sime Darby Joint Venture.
We wrote about this back at the RHC August result, and so it is pleasing to see the company hit a milestone. The market had become very worried about Ramsay’s balance sheet, and this will permit Ramsay to degear materially. That’s good!
It is also pleasing in that overseas expansions have been a shocker, for nearly every company on the ASX, Ramsay, alas, included. The Australian business is a good one, and Ramsay will almost certainly use the SD Joint Venture proceeds to bid for Cura, the Australian hospital business (a much smaller, almost bolt on type acquisition).
So, less debt, and more Australia (where the network efficiencies are greater; stronger links to doctors, a better brand, a stronger understanding of the legal and regulatory requirements, better buying power, more ability to allocate resources within the hospital footprint) is, we think, a very good thing.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.